Clinical Trial Update: A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of Geodon in Bipolar I Depression has completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-03-24